# TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

> **NCT00164463** · PHASE2 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 72 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT00164463
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164463, "TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00164463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*